LONDON: Shield Therapeutics plc (LON: STX) announced that trading in the Company’s Ordinary Shares of nominal value of £0.015 each began on the OTCQX Best Market (OTCQX) in the United States, under the ticker symbol “SHIEF”. By trading on the premium OTCQX, Shield’s shares will be available to US investors during US working hours and…